期刊文献+

早产新生儿肺表面活性物质合成水平与呼吸窘迫综合征的关系 被引量:5

Respiratory distress syndrome caused by deficiency of pulmonary surfactant in premature infants
下载PDF
导出
摘要 目的探讨早产新生儿肺表面活性物质(pulmonary surfactant,PS)的合成水平,及其与新生儿呼吸窘迫综合症(neonatal respiratory distress syndrome,NRDS)的关系。方法以该院35例早产新生儿(胎龄26~31周)为研究对象,均表现为明显的NRDS症状,需要行气管插管。在此期间,收集患儿气管插管中的气管吸出物,直至第8周为止;另以其他术中需行气管插管的新生儿作为正常对照。对各组样品的总蛋白质含量进行定量检测;并且用免疫印迹法,在各个时间点,对表面活性物质蛋白(surfactant protein,SP)-A,SP-B和SP-C表达水平的改变做半定量分析。结果35例患有NRDS的早产新生儿,在出生1周以内,其气管吸出物中PS的各种组分,如SP-A,SP-B和SP-C的水平都显著低于正常新生儿(P<0.01)。其中,SP-A和SP-B的水平在早产新生儿出生后的2周内开始逐步上升;而SP-C的水平则从第3周开始才显示上升的趋势。结论NRDS的发生主要和PS的低水平表达有明显的相关性。在研究的3种PS组分中,SP-C水平的改善与症状缓解的关系最为密切,它的缺乏可能对NRDS的发生有决定作用。 [Objective] To determine the synthesis level of pulmonary suffaetant in premature infants and its relationship with neonatal respiratory distress syndrome. [Methods] Thirty-five premature infants of 23-31 weeks of gestation requiring intubation for respiratory support were enrolled for this study. Tracheal aspirate samples were colleered from the infants at variant time point weekly until extubation at the 8th week. Control samples were also colleeted from other newborn term infants without lung disease who were intubated for surgieal procedures. Total protein composition in the samples was measured by the Bradford assay and the production and alteration of the Surfaetant Protein-A, -B, and -C was analyzed by using Western Blot. [Results] Among these 35 premature infants with NDRS, all the eontents of PS in their traeheal aspirate samples were signitieantly lower than those in the controls from term infants. The major postnatal inereases for SP-A and SP-B oeeurred during the 2nd weeks and SP-C reaehed plateau values till the 3rd weeks. [Conclusion] Both surfaetant defieieney and dysfunetion may eause NRDS in premature infants. They uniformly have low eoneentrations of SPs, espeeially the SP-C.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2007年第13期1640-1642,共3页 China Journal of Modern Medicine
关键词 早产新生儿 肺表面活性物质 呼吸窘迫综合征 气管吸出物 premature infant pulmonary surfaetant respiratory distress syndrome tracheal aspirate
  • 相关文献

参考文献11

  • 1VELDHUIZEN R,POSSMAYER F.Phospholipid metabolism in lung surfactant[J].Subcell Biochem,2004,37:359-388.
  • 2迟春花,何冰,汤秀英,李湘燕.老年大鼠肺表面活性物质相关蛋白CmRNA表达[J].中国现代医学杂志,2006,16(5):741-742. 被引量:4
  • 3DANIELS CB,ORGEIG S.Pulmonary surfactant:the key to the evolution of air breathing[J].News Physiol Sci,2003,18:151-157.
  • 4CROUCH E,WRIGHT JF.Surfactant proteins A and D and pulmonary host defense[J].Annu Rev Physiol,2001,63:521-554.
  • 5SAVANI RC,GODINEZ RI,GODINEZ MH,et al.Respiratory distress after intratracheal bleomycin:selective deficiency of surfactant proteins B and C[J].Am J Physiol Lung Cell Mol Physiol,2001,281(3):L685-696.
  • 6MILDENBERGER E,DEMELLO DE,LIN Z,et al.Focal congenital alveolar proteinosis associated with abnormal surfactant protein B messenger RNA[J].Chest,2001,119(2):645-647.
  • 7SOLARIN KO,WANG WJ,BEERS MF.Synthesis and post-translational processing of surfactant protein C[J].Pediatr Pathol Mol Med,2001,20:471-500.
  • 8GLASSER SW,BURHANS MS,KORFHAGEN TR,et al.Altered stability of pulmonary surfactant in SP-C-deficient mice[J].Proc Natl Acad Sci USA,2001,98:6366-6371.
  • 9GLASSER SW,DETMER EA,IKEGAMI M,et al.Pneumonitis and emphysema in SP-C gene targeted mice[J].J Biol Chem,2003,278:14291-14298.
  • 10VAYRYNEN O,GLUMOFF V,HALLMAN M.Regulation of surfactant proteins by LPS and proinflammatory cytokines in fetal and newborn lung[J].Am J Physiol Lung Cell Mol Physiol,2002,282(4):L803-810.

二级参考文献11

  • 1邱晨,史菲,陈彩霞.哮喘发作期肺表面活性物质对T细胞亚群的影响(英文)[J].中国现代医学杂志,2005,15(6):806-808. 被引量:4
  • 2PETTENAZZO A, JOBE A, HUMME J, et al. Clearance of surfactant phosphatidylcholine via the upper airways in rabbits[J]. J Appl Physiol, 1988, 65(5): 2151-2155.
  • 3PINOT F, BACHELET M, FRANCOIS D, et al. Modified natural porcine surfactant modulates tobacco smoke-induced stress response in human monocyles [J]. Life Science, 1999, 64 (2): 125-134.
  • 4WIRTZ HR, SCHMIDT M, Acute influence of cigarette smoke on secretion of pulmonary surfactant in rat alveolar type Ⅱ cells in culture[J]. Eur Respir J, 1996, 9 (1): 24-32.
  • 5OTTO-VERBERNE CJM. TEN-HAVE-OPBROEK AA, WILLEMS LN, et al. Lack of type Ⅱ cells and emphysema in human lungs[J]. Eur Respir J, 1991, 4(3): 316-323.
  • 6POELMA DL, ZIMMERMANN LJ, SCHOLTEN HH, et al. In vivo and in vitro uptake of surfactant lipids by alveolar type Ⅱ ceils and macrophages[J]. Am J Physiol Lung Cell Mol Physiol, 2002, 283(3): L648-L654.
  • 7GRIESE M. Pulmonary surfactant in health and human lung diseases: state of the art[J]. Eur Raspir J, 1999, 13(6): 1455-1476.
  • 8BETSUYAKU T, KUROKI Y, NAGAI K, et al, Effects of aging and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid[J], Eur Respir J, 2004, 24(6): 964-970.
  • 9WOHLFORD-LENANE CL, DURHAM PL, SNYDER JM. Localization of suffactant-associated protein C (SP-C) mRNA in fetal rabbit lung tissue by in situ hybridization[J]. Am J Respir Cell Mol Biol, 1992, 6(2): 225-234.
  • 10BARTH PJ, MULLER B. Effects of nitrogen dioxide exposure on Clara cell proliferation and morphology [J]. Pathol Res Pract, 1999, 195(7): 487-493.

共引文献3

同被引文献41

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部